Investigating the rise of robotic lung surgeries
Official title: The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience
Run by M.D. Anderson Cancer Center · NCT04644952 · Data updated 2026-11-12
This study looks at how often robotic surgeries for lung cancer are being done compared to traditional methods to see how they affect patient outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 15, 2020 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT04644952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who underwent lung resections between 2004 and 2019.
✕Probably not a fit
Patients who have not undergone lung resections or those treated outside the specified time frame may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the increasing frequency of robotic atypical segmentectomies for lung carcinoma by retrospectively reviewing patient data from 2004 to 2019. The primary objectives include evaluating the annual rate of robotic segmentectomies and comparing them to traditional surgical methods such as open surgery and video-assisted thoracic surgery (VATS). By analyzing these trends, researchers aim to understand the impact of robotic surgery on lung resection outcomes.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness and advantages of robotic surgery for lung cancer patients.
How similar studies have gone: Other studies have shown promising results with robotic surgical techniques, indicating potential benefits in surgical outcomes, making this approach relevant and timely.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent a lung resection from 2004 to 2019
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: David C Rice — M.D. Anderson Cancer Center
- Study coordinator: David C. Rice
- Email: drice@mdanderson.org
- Phone: 713-563-9153
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
-
Lung Toolkit: a tailored education program to help AI/AN cigarette smokers learn about lung cancer and screening
A Lung Toolkit education program is tested to see if it improves knowledge about lung cancer and screening among American Indian and Alaska Native cigarette smokers aged 50–80.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Restorative Justice–Based Lung Cancer Screening Support for Black Individuals to See if Screening Increases Uptake
This trial tests a restorative justice–based decision-making support to see if it increases lung cancer screening among Black adults who smoke or recently stopped.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Support for Veterans with lung cancer.
This study will test whether weekly phone support from a trained lay health worker can improve quality of life for Veterans who are newly diagnosed with lung cancer or who finished treatment within the past year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.